Inactivated Vaccine Market - Global Outlook and Forecast 2021-2027

Code: RW00014521886
Market Monitor Global
Oct-2021
Life Sciences
94 Pages

This report contains market size and forecasts of Inactivated Vaccine in Global, including the following market information:
Global Inactivated Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Inactivated Vaccine market was valued at 5983.1 million in 2020 and is projected to reach US$ 6775.5 million by 2027, at a CAGR of 3.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inactivated Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inactivated Vaccine Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Inactivated Vaccine Market Segment Percentages, By Type, 2020 (%)
Children Inactivated Vaccine
Adult Inactivated Vaccine

China Inactivated Vaccine Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Inactivated Vaccine Market Segment Percentages, By Application, 2020 (%)
Hospital
Medical Center

Global Inactivated Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Inactivated Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Inactivated Vaccine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Inactivated Vaccine Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Astellas Pharma(Japan)
CSL Limited(Australia)
Emergent BioSolutions(U.S.)
GlaxoSmithKline(U.K.)
Johnson & Johnson(U.S.)
MedImmune(U.S.)
Merck & Co(U.S.)
Pfizer(U.S.)
Sanofi Pasteur(France)
Serum Institute of India Pvt(India)

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Inactivated Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Vaccine Overall Market Size
2.1 Global Inactivated Vaccine Market Size: 2021 VS 2027
2.2 Global Inactivated Vaccine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Inactivated Vaccine Players in Global Market
3.2 Top Global Inactivated Vaccine Companies Ranked by Revenue
3.3 Global Inactivated Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Inactivated Vaccine Companies in Global Market, by Revenue in 2020
3.5 Global Companies Inactivated Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inactivated Vaccine Players in Global Market
3.6.1 List of Global Tier 1 Inactivated Vaccine Companies
3.6.2 List of Global Tier 2 and Tier 3 Inactivated Vaccine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Vaccine Market Size Markets, 2021 & 2027
4.1.2 Children Inactivated Vaccine
4.1.3 Adult Inactivated Vaccine
4.2 By Type - Global Inactivated Vaccine Revenue & Forecasts
4.2.1 By Type - Global Inactivated Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Inactivated Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Inactivated Vaccine Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inactivated Vaccine Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Medical Center
5.2 By Application - Global Inactivated Vaccine Revenue & Forecasts
5.2.1 By Application - Global Inactivated Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Inactivated Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Inactivated Vaccine Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Inactivated Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Inactivated Vaccine Revenue & Forecasts
6.2.1 By Region - Global Inactivated Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Inactivated Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Inactivated Vaccine Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Inactivated Vaccine Revenue, 2016-2027
6.3.2 US Inactivated Vaccine Market Size, 2016-2027
6.3.3 Canada Inactivated Vaccine Market Size, 2016-2027
6.3.4 Mexico Inactivated Vaccine Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Inactivated Vaccine Revenue, 2016-2027
6.4.2 Germany Inactivated Vaccine Market Size, 2016-2027
6.4.3 France Inactivated Vaccine Market Size, 2016-2027
6.4.4 U.K. Inactivated Vaccine Market Size, 2016-2027
6.4.5 Italy Inactivated Vaccine Market Size, 2016-2027
6.4.6 Russia Inactivated Vaccine Market Size, 2016-2027
6.4.7 Nordic Countries Inactivated Vaccine Market Size, 2016-2027
6.4.8 Benelux Inactivated Vaccine Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Inactivated Vaccine Revenue, 2016-2027
6.5.2 China Inactivated Vaccine Market Size, 2016-2027
6.5.3 Japan Inactivated Vaccine Market Size, 2016-2027
6.5.4 South Korea Inactivated Vaccine Market Size, 2016-2027
6.5.5 Southeast Asia Inactivated Vaccine Market Size, 2016-2027
6.5.6 India Inactivated Vaccine Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Inactivated Vaccine Revenue, 2016-2027
6.6.2 Brazil Inactivated Vaccine Market Size, 2016-2027
6.6.3 Argentina Inactivated Vaccine Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Inactivated Vaccine Revenue, 2016-2027
6.7.2 Turkey Inactivated Vaccine Market Size, 2016-2027
6.7.3 Israel Inactivated Vaccine Market Size, 2016-2027
6.7.4 Saudi Arabia Inactivated Vaccine Market Size, 2016-2027
6.7.5 UAE Inactivated Vaccine Market Size, 2016-2027
7 Players Profiles
7.1 Astellas Pharma(Japan)
7.1.1 Astellas Pharma(Japan) Corporate Summary
7.1.2 Astellas Pharma(Japan) Business Overview
7.1.3 Astellas Pharma(Japan) Inactivated Vaccine Major Product Offerings
7.1.4 Astellas Pharma(Japan) Inactivated Vaccine Revenue in Global (2016-2021)
7.1.5 Astellas Pharma(Japan) Key News
7.2 CSL Limited(Australia)
7.2.1 CSL Limited(Australia) Corporate Summary
7.2.2 CSL Limited(Australia) Business Overview
7.2.3 CSL Limited(Australia) Inactivated Vaccine Major Product Offerings
7.2.4 CSL Limited(Australia) Inactivated Vaccine Revenue in Global (2016-2021)
7.2.5 CSL Limited(Australia) Key News
7.3 Emergent BioSolutions(U.S.)
7.3.1 Emergent BioSolutions(U.S.) Corporate Summary
7.3.2 Emergent BioSolutions(U.S.) Business Overview
7.3.3 Emergent BioSolutions(U.S.) Inactivated Vaccine Major Product Offerings
7.3.4 Emergent BioSolutions(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.3.5 Emergent BioSolutions(U.S.) Key News
7.4 GlaxoSmithKline(U.K.)
7.4.1 GlaxoSmithKline(U.K.) Corporate Summary
7.4.2 GlaxoSmithKline(U.K.) Business Overview
7.4.3 GlaxoSmithKline(U.K.) Inactivated Vaccine Major Product Offerings
7.4.4 GlaxoSmithKline(U.K.) Inactivated Vaccine Revenue in Global (2016-2021)
7.4.5 GlaxoSmithKline(U.K.) Key News
7.5 Johnson & Johnson(U.S.)
7.5.1 Johnson & Johnson(U.S.) Corporate Summary
7.5.2 Johnson & Johnson(U.S.) Business Overview
7.5.3 Johnson & Johnson(U.S.) Inactivated Vaccine Major Product Offerings
7.5.4 Johnson & Johnson(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson(U.S.) Key News
7.6 MedImmune(U.S.)
7.6.1 MedImmune(U.S.) Corporate Summary
7.6.2 MedImmune(U.S.) Business Overview
7.6.3 MedImmune(U.S.) Inactivated Vaccine Major Product Offerings
7.6.4 MedImmune(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.6.5 MedImmune(U.S.) Key News
7.7 Merck & Co(U.S.)
7.7.1 Merck & Co(U.S.) Corporate Summary
7.7.2 Merck & Co(U.S.) Business Overview
7.7.3 Merck & Co(U.S.) Inactivated Vaccine Major Product Offerings
7.4.4 Merck & Co(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.7.5 Merck & Co(U.S.) Key News
7.8 Pfizer(U.S.)
7.8.1 Pfizer(U.S.) Corporate Summary
7.8.2 Pfizer(U.S.) Business Overview
7.8.3 Pfizer(U.S.) Inactivated Vaccine Major Product Offerings
7.8.4 Pfizer(U.S.) Inactivated Vaccine Revenue in Global (2016-2021)
7.8.5 Pfizer(U.S.) Key News
7.9 Sanofi Pasteur(France)
7.9.1 Sanofi Pasteur(France) Corporate Summary
7.9.2 Sanofi Pasteur(France) Business Overview
7.9.3 Sanofi Pasteur(France) Inactivated Vaccine Major Product Offerings
7.9.4 Sanofi Pasteur(France) Inactivated Vaccine Revenue in Global (2016-2021)
7.9.5 Sanofi Pasteur(France) Key News
7.10 Serum Institute of India Pvt(India)
7.10.1 Serum Institute of India Pvt(India) Corporate Summary
7.10.2 Serum Institute of India Pvt(India) Business Overview
7.10.3 Serum Institute of India Pvt(India) Inactivated Vaccine Major Product Offerings
7.10.4 Serum Institute of India Pvt(India) Inactivated Vaccine Revenue in Global (2016-2021)
7.10.5 Serum Institute of India Pvt(India) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Inactivated Vaccine Market Opportunities & Trends in Global Market
Table 2. Inactivated Vaccine Market Drivers in Global Market
Table 3. Inactivated Vaccine Market Restraints in Global Market
Table 4. Key Players of Inactivated Vaccine in Global Market
Table 5. Top Inactivated Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Inactivated Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Inactivated Vaccine Revenue Share by Companies, 2016-2021
Table 8. Global Companies Inactivated Vaccine Product Type
Table 9. List of Global Tier 1 Inactivated Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inactivated Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE